GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 111 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $359,000 | +552.7% | 24,578 | +82.7% | 0.06% | +321.4% |
Q1 2020 | $55,000 | -38.2% | 13,452 | -8.1% | 0.01% | +16.7% |
Q3 2019 | $89,000 | -2.2% | 14,632 | +3.1% | 0.01% | +140.0% |
Q2 2018 | $91,000 | -79.9% | 14,196 | -59.8% | 0.01% | -79.2% |
Q1 2017 | $452,000 | – | 35,290 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |